226 related articles for article (PubMed ID: 16522454)
1. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down.
Bateman ED; Jacques L; Goldfrad C; Atienza T; Mihaescu T; Duggan M
J Allergy Clin Immunol; 2006 Mar; 117(3):563-70. PubMed ID: 16522454
[TBL] [Abstract][Full Text] [Related]
2. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
4. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
Koenig SM; Ostrom N; Pearlman D; Waitkus-Edwards K; Yancey S; Prillaman BA; Dorinsky P
J Asthma; 2008 Oct; 45(8):681-7. PubMed ID: 18951261
[TBL] [Abstract][Full Text] [Related]
5. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
Miyagawa T
Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
[TBL] [Abstract][Full Text] [Related]
6. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
7. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
10. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.
Angus R; Reagon R; Cheesbrough A
Int J Clin Pract; 2005 Feb; 59(2):156-62. PubMed ID: 15854190
[TBL] [Abstract][Full Text] [Related]
11. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
13. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
Ankerst J
J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
15. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
[TBL] [Abstract][Full Text] [Related]
16. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
[TBL] [Abstract][Full Text] [Related]
17. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
18. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
Matz J; Emmett A; Rickard K; Kalberg C
J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343
[TBL] [Abstract][Full Text] [Related]
19. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
[TBL] [Abstract][Full Text] [Related]
20. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
